Similar articles

• Tumor markers in urologic cancer.

  Javadpour N. Javadpour N. Urology. 1980 Aug;16(2):127-36. doi: 10.1016/0090-4295(80)90065-5. Urology. 1980. PMID: 6157242 Review. No abstract available.
• Murine hybridoma antibodies against human transitional carcinoma-associated antigens.

  Messing EM, Bubbers JE, Whitmore KE, deKernion JB, Nestor MS, Fahey JL. Messing EM, et al. J Urol. 1984 Jul;132(1):167-72. doi: 10.1016/s0022-5347(17)49512-7. J Urol. 1984. PMID: 6202893
• Tumour markers in urology: aids in cancer diagnosis and management.

  Wahren B. Wahren B. Urol Res. 1979 Jun 22;7(2):57-67. doi: 10.1007/BF00254682. Urol Res. 1979. PMID: 89748 No abstract available.
• Serum and cellular biologic tumor markers in patients with urologic cancer.

  Javadpour N. Javadpour N. Hum Pathol. 1979 Sep;10(5):557-68. doi: 10.1016/s0046-8177(79)80099-4. Hum Pathol. 1979. PMID: 93569
• [Monoclonal antibodies in urology. Basic theories and clinical applications].

  Guiter J. Guiter J. Ann Urol (Paris). 1985;19(1):7-12. Ann Urol (Paris). 1985. PMID: 3885840 Review. French.